Charles Swanton
M.D., Ph.D., FRCP, FMedSci, FRS
Group Leader; Chief Clinician, Cancer Research UK
👥Biography 个人简介
Charles Swanton is a world leader in understanding tumor evolution and heterogeneity. His TRACERx study is a landmark prospective cohort study tracking lung cancer evolution from diagnosis through treatment and relapse. Swanton's work on chromosomal instability and tumor phylogenetics has transformed understanding of cancer progression and resistance.
Charles Swanton是理解肿瘤进化和异质性的世界领导者。他的TRACERx研究是一项里程碑式的前瞻性队列研究,追踪肺癌从诊断到治疗和复发的进化。Swanton在染色体不稳定性和肿瘤系统发育方面的工作改变了对癌症进展和耐药性的理解。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
TRACERx Study
Leading longitudinal study of lung cancer evolution tracking intratumor heterogeneity.
Chromosomal Instability
Characterized CIN as driver of tumor evolution and drug resistance.
Representative Works 代表性著作
Tracking the Evolution of Non-Small-Cell Lung Cancer
New England Journal of Medicine (2017)
TRACERx prospective cohort study.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-03-05 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Charles Swanton 的研究动态
Follow Charles Swanton's research updates
留下邮箱,当我们发布与 Charles Swanton(Francis Crick Institute / UCL Cancer Institute)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment